RYTM Dividend: Rhythm Pharmaceuticals Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	174	130	77	23	3	0
Revenue Growth (YoY)	26%	69%	235%	667%	--	--
Cost of Revenue	18	13	9	2	0	--
Gross Profit	155	116	68	21	2	--
Selling, General & Admin	175	144	117	92	68	46
Research & Development	166	237	134	108	104	90
Operating Expenses	342	382	252	200	172	136
Other Non Operating Income (Expenses)	1	2	0	0	100	--
Pretax Income	-191	-260	-184	-181	-69	-134
Income Tax Expense	0	0	0	--	0	--
Net Income	-197	-264	-184	-181	-69	-134
Net Income Growth	-51%	43%	2%	162%	-49%	-4%
Shares Outstanding (Diluted)	66.26	60.99	57.67	52.12	49.6	44.13
Shares Change (YoY)	8%	6%	11%	5%	12%	21%
EPS (Diluted)	-2.98	-4.33	-3.2	-3.47	-1.4	-3.04
EPS Growth	-55%	35%	-8%	148%	-54%	-21%
Free Cash Flow	-109	-113	-136	-173	-146	-122
Free Cash Flow Per Share	-1.64	-1.85	-2.35	-3.31	-2.94	-2.76
Gross Margin	89.08%	89.23%	88.31%	91.3%	66.66%	--
Operating Margin	-106.89%	-203.84%	-238.96%	-778.26%	-5,666.66%	0%
Profit Margin	-113.21%	-203.07%	-238.96%	-786.95%	-2,300%	0%
Free Cash Flow Margin	-62.64%	-86.92%	-176.62%	-752.17%	-4,866.66%	0%
EBITDA	-185	-264	-183	-178	-169	-136
EBITDA Margin	-106.32%	-203.07%	-237.66%	-773.91%	-5,633.33%	0%
D&A For EBITDA	1	1	1	1	1	0
EBIT	-186	-265	-184	-179	-170	-136
EBIT Margin	-106.89%	-203.84%	-238.96%	-778.26%	-5,666.66%	0%
Effective Tax Rate	0%	0%	0%	--	0%	--

Rhythm Pharmaceuticals Inc (RYTM) Price